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The case we report shows rapid progression and a very poor prognosis only for a month that diﬀers from the clinical course
reported in the literature. An 83-year-old man was referred to our hospital for macroscopic hematuria. Computed tomography
(CT) revealed a large bladder tumor measuring 4cm×3cm and magnetic resonance imaging revealed extravesical invasion
and pelvic wall invasion of the tumors. Chest CT and bone scintigraphy revealed no evidence of distant visceral metastases,
and a clinical diagnosis of T4N0M0 was made. Transurethral resection of the bladder tumor (TUR-BT) was performed for
histopathological diagnosis 18 days after admission, and no further adjuvant treatment was given. At 15 days after TUR-BT, the
patient’s clinical status worsened with symptoms of exertional dyspnea. CT showed multiple metastatic lesions in the lung, liver,
and retroperitoneal lymphadenopathy. The patient died 2 days later and underwent autopsy. A ﬁnal histopathological diagnosis of
leiomyosarcoma was made based on immunohistochemical staining.
1.Introduction
Nonepithelial urinary bladder tumors account for less than
5% of bladder malignancies overall, with leiomyosarcoma
comprising 0.1% of all bladder cancers [1] .T h e r ei sal a c k
of consensus on a standard treatment, and little is known
about the natural history and prognosis of urinary bladder
leiomyosarcoma due to its very low incidence. The case we
report shows rapid progression and a very poor prognosis
onlyforamonththatdiﬀersfromtheclinicalcoursereported
in the literature.
2.Casereport
An 83-year-old man was referred to our hospital for macro-
scopic hematuria and dysuria, and his general condition
was poor. Cystoscopy revealed a large broad-based non-
papillarybladdertumorontherightbladderwall.Computed
tomography (CT) revealed a large bladder tumor measuring
4cm × 3cm and right hydronephrosis (Figure 1(a)), and
magnetic resonance imaging revealed extravesical invasion
and pelvic wall invasion of the tumors (Figure 1(b)). Chest
CT and bone scintigraphy revealed no evidence of distant
visceral metastases, and a clinical diagnosis of T4N0M0 was
made.
Transurethral resection of the bladder tumor (TUR-BT)
was performed for histopathological diagnosis 18 days after
admission, and Leiomyosarcoma was suspected histopatho-
logically. Because of his advanced age and poor performance
status, radical cystectomy was not available and no further
adjuvant treatment was given. At 15 days after TUR-BT,
the patient’s clinical status worsened with symptoms of
exertional dyspnea. CT showed multiple metastatic lesions
in the lung, liver, and retroperitoneal lymphadenopathy.
The patient died 2 days later and underwent autopsy. The
autopsy revealed macroscopic multiple metastatic lesions
in the bilateral lungs, pleura, diaphragm and liver, and
retroperitoneal lymphadenopathy. A ﬁnal histopathological
diagnosis of leiomyosarcoma was made based on immuno-
histochemical staining, which revealed positive staining for
α-smooth muscle actin and vimentin and negative staining
for cytokeratin (Figures 1(c) and 1(d)).
3. Discussion
Urinary bladder leiomyosarcoma is relatively rare, with few
large series reported in the literature. Rosser et al. [2]
reported 36 cases, and Lee et al. [3]r e p o r t e d2 0c a s e s
of urinary bladder leiomyosarcoma. According to Rosser2 Case Reports in Urology
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Figure 1: (a) Computed tomography shows a large bladder tumor measuring 4cm × 3cm and right hydronephrosis. (b) Magnetic
resonance imaging shows extravesical invasion of the tumors. (c) Hematoxylin-eosin stain shows leiomyosarcoma of the bladder tumor.
(d) Immunohistochemical staining of the bladder tumor is positive for α-smooth muscle actin.
et al. [2], the most common clinical presentation is gross
hematuria (81%) followed by dysuria (19%) and pollakiuria
(28%). Our patient was referred to us with macroscopic
hematuria, but he had no symptoms until the tumor reached
an advanced stage and became locally invasive.
Urinary bladder leiomyosarcomas have always been
considered highly aggressive tumors that require aggressive
surgical extirpation, and radical cystectomy with wide
margins should be performed whenever possible [4, 5].
Neoadjuvant and adjuvant therapies were used in 21%
and 16% of patients at MD Anderson, respectively, and
both resulted in a doubling of disease-speciﬁc survival.
However,thisresultwasnotstatisticallysigniﬁcant,reﬂecting
the small number of patients in each group. Similarly,
it is diﬃcult to evaluate the impact of neoadjuvant and
adjuvant chemotherapy on quality of life [4, 5]. Patients
with positive surgical margin could be candidates for
adjuvant radiotherapy. Patients with local recurrence or
metastatic bladder sarcomas should be treated with systemic
chemotherapy (as sarcoma chemotherapy protocol using
doxorubicin, ifosfamide, cisplatin, and docetaxel), and/or
radiotherapy [4, 5]. Contemporary studies suggest that these
tumors may have a better prognosis than once believed and
show remarkable 5-year-disease-speciﬁc survival rates of 59–
62% [2, 4].
Some studies suggest that patients with bladder
leiomyosarcoma with low mitotic activity (<5p e r1 0H P F )
and mild-to-moderate nuclear atypia have a good prognosis,
whereas those with higher mitotic activity (5p e r
10HPF) have a worse prognosis [3]. In our patient, theCase Reports in Urology 3
leiomyosarcoma was diagnosed with high grade mitotic
activity (10 per 10HPF). However, no statistically relevant
evidence regarding therapeutic behavior can be found in the
literature. Therefore, present treatment should be tailored
on a case-by-case basis. Our patient showed unexpectedly
rapid progression and a very poor prognosis after TUR-
BT; therefore, if feasible, aggressive surgical excision and
adjuvant therapy should be performed as early as possible in
cases of bladder leiomyosarcoma.
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